The Merck Group Website
The Merck Group Website

Press Releases


2015


06/17/15EMD Serono Announces € 1.2 million Grant for Fertility Innovation (GFI) for 2015 / 16
Rockland, Massachusetts
PDF
06/08/15Merck KGaA, Darmstadt, Germany, Illumina and Genea Form the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment
Rockland, Massachusetts
PDF
06/03/15Merck KGaA, Darmstadt, Germany Celebrates 125 Years in the U.S. with Launch of “Smarter, Together” Initiative
Billerica, Massachusetts
PDF
05/28/15Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 
Rockland, Massachusetts
 PDF
05/28/15EMD Serono Continues its Entry into Oncology with the Key Appointments of David Trexler to Senior Vice President of Oncology Commercial and Zhen Su, MD, MBA to Vice President of Medical Oncology
Rockland, Massachusetts
PDF
05/21/15Rebif® (interferon beta-1a) Data at CMSC Annual Meeting Highlights Clinical and MRI Predictors for Long Term Outcomes 
Rockland, Massachusetts
 PDF
05/15/15Merck KGaA, Darmstadt, Germany to Present Data at ASCO that Illustrate how the Company is Tackling Difficult-to-Treat Cancers
Rockland, Massachusetts
PDF
05/13/15Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
Darmstadt, Germany, and New York, US
PDF
05/12/15Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer
Rockland, Massachusetts
PDF
05/06/15EMD Serono Initiates Co-Promotion of XALKORI® (crizotinib) with Pfizer in the United States
Rockland, Massachusetts
PDF
04/21/15Remembering Thorsten Eickenhorst, MD, PhD
March 30, 1962 - April 18, 2015
 PDF
04/20/15Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer
Darmstadt, Germany, and New York, US
PDF
04/16/15Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development
Rockland, Massachusetts
 PDF
04/16/15EMD Serono Highlights Scientific Commitment to MS with Data Presented at the AAN Annual Meeting
Rockland, Massachusetts
 PDF
04/07/15Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib)
Darmstadt, Germany, and New York, US
PDF
04/07/15EMD Serono Launches 11th Edition of The EMD Serono Specialty Digest™ at Annual Meeting of The Academy of Managed Care Pharmacy
Rockland, Massachusetts
 PDF
04/01/15EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology
Rockland, Massachusetts
PDF
03/30/15The Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany, and Intrexon Announce Agreement for the Development and Commercialization of CAR-T Therapy
Rockland, Massachusetts
PDF
03/12/15EMD Serono Announces Strategic Collaboration with Illumina for Diagnostics in Oncology
Rockland, Massachusetts

PDF
03/09/15EMD Serono and Opexa Amend Agreement to Support Ongoing Development of Tcelna (imilecleucel-T) for Multiple Sclerosis
Rockland, Massachusetts

PDF

2014
12/10/14EMD Serono Continues Leadership Role in Product Integrity by Launching Product Tracking Program and Check My Meds TM Smartphone App
Rockland, Massachusetts
PDF
12/04/14EMD Serono Awards Grant for Growth - Countdown for Accepting Applications 
Rockland, Massachusetts
PDF
10/07/14EMD Serono to Collaborate with The Institute of Cancer Research, London, and Wellcome Trust to Co-Develop Anti-Cancer Drugs
Rockland, Massachusetts
PDF
10/01/14EMD Serono Announces Award of $1.3 Million to the Winners of the first Grant for Oncology Innovation
Rockland, Massachusetts
PDF
09/19/14EMD Serono Awards Grant for Growth Innovation (GGI) for the first time
Rockland, Massachusetts
PDF
09/17/14EMD Serono and Sutro Biopharma to Partner on Development of Antibody Drug Conjugates
Rockland, Massachusetts
PDF
09/12/14EMD Serono Honors Recipients of the Second Annual €1 Million Grant for Multiple Sclerosis Innovation
Rockland, Massachusetts
PDF
09/10/14EMD Serono and Accelerated Cure Project Launch Collaborative Research Program to Optimize Treatment and Understand Progression of Multiple Sclerosis
Rockland, Massachusetts
PDF
09/09/14EMD Serono Presents New Data on Rebif ® (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston
Rockland, Massachusetts
PDF
09/02/14EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology
Rockland, Massachusetts
 PDF
09/02/14EMD Serono and Massachusetts General Hospital Collaborate to Better Understand Systemic Lupus Erythematosus and Lupus Nephritis 
Billerica, Massachusetts
PDF
07/29/14EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
Rockland, Massachusetts
PDF
07/08/14EMD Serono Participates in Global Grants Program to Fund Scientific Innovation and Medical Education
Rockland, Massachusetts
 PDF
07/01/14EMD Serono Commits € 2 million to the Grant for Fertility Innovation (GFI) for 2014 /15  
Rockland, Massachusetts
 PDF
06/24/14EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
Rockland, Massachusetts
 PDF
06/11/14EMD Serono Launches Compassionate Corps Program to Reduce Cost of Fertility Treatment for Eligible Military Veterans and their Spouses
Rockland, Massachusetts
 PDF
05/29/14EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers
Rockland, Massachusetts
 PDF
05/28/14EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Demonstrates Continued Commitment to Patients with Relapsing MS
Rockland, Massachusetts
 PDF
04/25/14EMD Serono Presents New Data on Rebif®  (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting
Rockland, Massachusetts
 PDF
04/07/14EMD Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Rockland, Massachusetts
 PDF
04/01/14EMD Serono, Inc. Launches 10th Edition of The EMD Serono Specialty Digest™ at Annual Meeting of The Academy of Managed Care Pharmacy
Rockland, Massachusetts
 PDF
04/01/14EMD Serono Enters into Research Agreement with Pfizer and Broad Institute
Rockland, Massachusetts
 PDF
02/13/14EMD Serono Strengthens Leadership With New Appointments
Rockland, Massachusetts
PDF

2013


12/17/13EMD Serono, Inc. and the National MS Society Announce Recipients of Funding for Multiple Sclerosis Research  
Rockland, Massachusetts
English  
12/16/13EMD Serono’s Redesigned Fertility Pen Available for Distribution in US  
Rockland, Massachusetts
English  
12/02/13EMD Serono’s new spin - off TocopheRx to focus on infertility treatment  
Rockland, Massachusetts
English  
11/08/13EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director  
Rockland, Massachusetts
 English  
10/28/13EMD Serono and Open Monoclonal Technology Expand Collaboration 
Rockland, Massachusetts
 English  
10/16/13EMD Serono Receives FDA Approval for Redesigned Fertility Pen 
Rockland, Massachusetts
English  
10/05/13EMD Serono Makes First Awards as Part of the Company’s €1 Million Grant for Multiple Sclerosis Innovation 
Rockland, Massachusetts
 English  
10/01/13EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre 
Rockland, Massachusetts
 English  
09/25/2013EMD Serono Announces Decision to Continue the Development of Tecemotide in Stage III Non-Small Cell Lung Cancer 
Rockland, Masschusetts
 English  
09/10/2013EMD Serono Chief Financial Officer Named to South Shore Hospital Board of Directors 
Rockland, Massachusetts
English  
08/30/2013EMD Serono President and Head of US Operations James Hoyes Resigns 
Rockland, Massachusetts
 English  
07/09/2013Commitment of €4 million made to the Grant for Fertility Innovation (GFI) for the years 2013 / 2014  
Rockland, Massachusetts
 English  
06/26/2013EMD Serono Establishes Immuno - Oncology Research and Early Development Platform to Advance Innovation in Cancer Therapies  
Rockland, Massachusetts
 English  
05/28/2013MS LifeLines® Call Center Earns J.D. Power and Associates Re-Certification for Customer Service Excellence in Providing Support Services to the MS Community 
Rockland, Massachusetts
 English  
05/16/2013EMD Serono’s Affiliate Increases MS Ventures Commitment to € 100 Million  
Rockland, Massachusetts
 English  
04/15/2013EMD Serono Expands Global Research & Development Hub in Massachusetts and Continues to Build Presence in US Pharmaceuticals Market 
Rockland, Massachusetts
 English  
04/15/2013EMD Serono Announces Appeals Court Decision 
Rockland, Massachusetts
 English  
02/25/2013EMD Serono: Phase III Trial of Cilengitide Did Not Meet Primary Endpoint in Patients With Newly Diagnosed Glioblastoma 
Rockland, Massachusetts
 English  
01/03/2013EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a) 
Rockland, Massachusetts/New York, NY
 English        
 

 

2012
12/20/2012EMD Serono, Inc. and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research
Rockland, Massachusetts
  English
12/19/2012EMD Serono: Phase III Trial of L-BLP25 (Stimuvax) in Patients with Non-Small Cell Lung Cancer Did not Meet Primary Endpoint
Rockland, Massachusetts
 English
10/18/2012EMD Serono and Auxogyn Announce Collaboration on Eeva™ Test
Rockland, Massachusetts
 English
10/11/2012EMD Serono Launches One Million Euro Research Grant for Multiple Sclerosis Innovation
Rockland, Massachusetts
 English
09/18/2012

EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include  U.S. Investigators 
Rockland, Massachusetts

 English
07/31/2012EMD Serono Announces Appointment of Dr. Thorsten Eickenhorst to US Leadership Team
Rockland, Massachusetts
 English
06/14/2012EMD Serono, Inc. Strengthens Leadership Teams with New
Appointments
Rockland, Massachusetts
 English
05/23/2012DR. ANNALISA JENKINS, EXECUTIVE VICE PRESIDENT, HEAD OF GLOBAL DRUG DEVELOPMENT AND MEDICAL FOR MERCK SERONO, HONORED BY GILDA’S CLUB NEW YORK CITY
Rockland, Massachusetts
 English
04/20/2012EMD SERONO TO PRESENT NEW DATA ON MULTIPLE SCLEROSIS AT THE AMERICAN ACADEMY OF NEUROLOGY’S 64TH ANNUAL MEETING
Rockland, Massachusetts
 English
04/17/2012EMD SERONO, INC. FOUNDING DONOR OF NEWLY LAUNCHED MGH MULTIPLE SCLEROSIS DISCOVERY FORUM
Rockland, Massachusetts
 English
01/23/2012MS LIFELINES EARNS J.D. POWER AND ASSOCIATES CALL CENTER CERTIFICATION FOR CUSTOMER SERVICE EXCELLENCE IN PROVIDING SUPPORT SERVICES TO THE MS COMMUNITY
Rockland, MA/New York, NY
 English
2011
10/19/2011EMD SERONO AND FAST FORWARD COMMIT $3 MILLION FOR MULTIPLE SCLEROSIS
Rockland, Massachusetts
 English
09/15/2011EMD SERONO, INC. HONORED AS A 2011 WORKING MOTHER 100 BEST COMPANY
Rockland, Massachusetts
 English
07/14/2011EMD SERONO, INC. ANNOUNCES APPOINTMENT OF JAMES HOYES AS PRESIDENT
Rockland, Massachusetts
 English
06/30/2011EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE RECIPIENTS OF FUNDING FOR MULTIPLE SCLEROSIS RESEARCH
Rockland, Massachusetts / New York, New York
 English
06/23/2011EMD SERONO INC. COMMITTED TO TRANSPARENCY IN INTERACTIONS WITH HEALTHCARE PROFESSIONALS AND ORGANIZATIONS
Rockland, Massachusetts
 English
06/09/2011EMD SERONO: PATIENT ENROLLMENT COMPLETED FOR CILENGITIDE'S PIVOTAL PHASE III TRIAL CENTRIC
Rockland, Massachusetts
 English
05/20/2011EMD SERONO PRESIDENT AND CEO FEREYDOUN FIROUZ RESIGNS
Rockland, Massachusetts
 English
05/04/2011EMD SERONO, INC. ANNOUNCES CIVIL SETTLEMENT
Rockland, Massachusetts
 English
04/28/2011EMD SERONO, INC. PROVIDES $1.5M GRANT TO MASSACHUSETTS GENERAL
Rockland, Massachusetts
 English
04/26/2011EMD SERONO, INC. RECEIVES GOLD LEED RATING
Rockland, Massachusetts
 English
04/08/2011EMD SERONO'S COMMITMENT TO ADVANCE MULTIPLE SCLEROSIS CARE AND RESEARCH UNDERSCORED BY DATA TO BE PRESENTED AT AAN 2011 MEETING
Rockland, Massachusetts
 English
03/24/2011EMD SERONO, INC. RECEIVES CEO CANCER GOLD STANDARD™ ACCREDITATION
Rockland, Massachusetts
 English
03/02/2011EMD SERONO RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Rockland, Massachusetts
 English
02/10/2011EMD SERONO HOLDS GRAND OPENING CEREMONY FOR NEW STATE-OF-THE-ART RESEARCH CENTER IN BILLERICA, MA
Rockland, Massachusetts
 English
2010
11/26/2010EMD SERONO ANNOUNCES EXTENSION OF FDA PRIORITY REVIEW PERIOD FOR CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS
Rockland, Massachusetts
 English
11/11/2010FDA APPROVES EGRIFTA (TESAMORELIN FOR INJECTION): FIRST AND ONLY TREATMENT FOR THE REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
Rockland, Massachusetts
 English
10/08/2010EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Rockland, Massachusetts
 English
09/01/2010MS LIFELINES REACHES MILESTONE OF SERVICING ONE MILLION IN-BOUND CALLS
Rockland, Massachusetts
 English
07/28/2010EMD SERONO, INC.: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS
Rockland, Massachusetts
 English
06/17/2010EMD SERONO RESUMES STIMUVAX CLINICAL PROGRAM IN LUNG CANCER
Rockland, Massachusetts
 English
06/05/2010

CILENGITIDE STUDY PROVIDES LONG-TERM FOLLOW-UP DATA IN GLIOBLASTOMA PATIENTS 
Rockland, Massachusetts

 English
05/05/2010EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS
Rockland, Massachusetts
 English
03/23/2010

EMD SERONO: STIMUVAX CLINICAL PROGRAM TEMPORARILY SUSPENDED
Geneva, Switzerland

English 
03/05/2010

EMD SERONO, INC. NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE 
Rockland, Massachusetts

English 
1/21/2010TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE
Rockland, Massachusetts
English
2009
12/16/2009EMD SERONO, INC. AND NATIONALLY RANKED US HOSPITAL ANNOUNCE COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS
Rockland, MA
 English
11/30/2009
EMD SERONO, INC. RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Rockland, MA
 English
10/19/2009
EMD SERONO, INC. HOLDS TOPPING OFF CEREMONY TO MARK MILESTONE IN EXPANSION OF THE COMPANY'S BILLERICA, MA RESEARCH FACILITY
Rockland, MA
 English
10/05/2009
EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE          
Rockland, MA
 English
09/30/2009
EMD SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE UNITED STATES          
Rockland, MA
 English
08/10/2009EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH, CLINICAL TRIALS         
Rockland, MA/Houston, TX
 English
05/27/2009MULTIPLE SCLEROSIS - WHAT ARE PEOPLE WITH MS AND THEIR HEALTH CARE PROVIDERS REALLY THINKING?          
Rockland, MA/New York, NY
 English
05/01/2009EMD Serono, Inc. and Fast Forward, LLC Commit $3 Million in 2009 To Early Stage Drug Development For Multiple Sclerosis
Rockland, MA/New York, NY
 English
04/29/2009

TWO-YEAR PHASE III DATA PRESENTED AT AAN 61ST ANNUAL MEETING SHOW POSITIVE OUTCOME OF CLADRIBINE TABLETS IN PATIENTS WITH MULTIPLE SCLEROSIS
Rockland, Massachusetts

 English
03/30/2009EMD SERONO: NEW PHASE III DATA FOR CLADRIBINE TABLETS TO BE PRESENTED AT THE AMERICAN ACademY OF NEUROLOGY 61ST ANNUAL MEETING IN APRIL 2009 
Rockland, Massachusetts
 English
03/30/2009

EMD SERONO ANNOUNCES EXPANSION WITH RESEARCH SITE IN CAMBRIdGE, MASSACHUSETTS
Rockland, Massachusetts

 English
03/18/2009EMD SERONO and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis
Rockland, Massachusetts
 English
01/23/2009EMD SERONO’S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE IN TWO-YEAR PHASE III PIVOTAL TRIAL
Rockland, Massachusetts
 English
01/12/2009

EMD Serono and Emmaus Medical Announce Promotional Rights Agreement for Zorbtive® in the United States
Rockland, Massachusetts

 English
2008
11/07/2008EMD SERONO LAUNCHES LANDMARK PATIENT REGISTRY FOR EGG FREEZING
Rockland, Massachusetts
 English
10/29/2008EMD SERONO AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES
Rockland, Massachusetts
 English
10/9/2008EMD SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Rockland, Massachusetts
 English
7/10/2008EMD SERONO, INC. TO ADOPT REVISED AND STRENGTHENED PHRMA CODE
Rockland, Massachusetts
English
4/16/2008EMD SERONO ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN MASSACHUSETTS
Geneva, Switzerland
English
 
top

MEDIA CONTACT

Lisa Buffington
Vice President
US Communications
EMD Serono, Inc.
Tel.:781-681-2340 

MEDIA KIT

Access PDF files and images relating to company facts, our leadership team, EMD Serono locations, and our therapeutic areas.